OKYO Pharma (OKYO) Stock Chart & Stock Price History $2.91 +0.30 (+11.49%) Closing price 03:59 PM EasternExtended Trading$2.91 0.00 (0.00%) As of 04:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OKYO Pharma Stock Price Performance The OKYO Pharma (OKYO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 142.50%, with a year-to-date return of 153.07%. In the past month, the stock has increased 66.29%, reflecting recent market activity. As of the latest close, OKYO Pharma traded at $2.61 with a market cap of $88.32 million and volume of 46,206 shares. Receive OKYO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for OKYO Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+18.78%1 Month Performance+66.29%3 Month Performance+132.80%Year-To-Date Performance+153.07%1 Year Performance+142.50% OKYO Stock Chart for Wednesday, July, 2, 2025 OKYO Chart by TradingView OKYO Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/01/2025$2.57$2.61+1.56%$2.66$2.4746,206 shs$88.32 million06/30/2025$2.45$2.57+4.90%$2.57$2.4353,064 shs$86.97 million06/27/2025$2.42$2.45+1.24%$2.46$2.4140,321 shs$82.91 million06/26/2025$2.47$2.42-2.02%$2.49$2.3748,491 shs$81.89 million06/25/2025$2.30$2.47+7.39%$2.48$2.3066,089 shs$83.58 million06/24/2025$2.19$2.30+5.02%$2.35$2.1837,401 shs$77.83 million06/23/2025$2.37$2.19-7.59%$2.37$2.05185,291 shs$74.11 million06/20/2025$2.25$2.37+5.33%$2.56$2.25803,430 shs$80.19 million06/19/2025$2.25$2.25$2.44$2.1287,998 shs$76.14 million06/18/2025$2.21$2.25+1.81%$2.44$2.1287,998 shs$76.14 million Get the Latest News and Ratings for OKYO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OKYO Pharma and its competitors with MarketBeat's FREE daily newsletter. 06/17/2025$2.56$2.21-13.67%$2.63$2.13201,376 shs$74.78 million06/16/2025$3.01$2.56-14.95%$3.11$2.50316,287 shs$86.62 million06/13/2025$2.53$3.01+18.97%$3.02$2.37262,698 shs$101.85 million06/12/2025$2.33$2.53+8.58%$2.58$2.33496,263 shs$85.61 million06/11/2025$2.07$2.33+12.56%$2.63$2.041.24 million shs$78.84 million06/10/2025$2.10$2.07-1.43%$2.13$2.0677,200 shs$70.04 million06/09/2025$1.90$2.10+10.53%$2.11$1.85129,551 shs$71.06 million06/06/2025$1.86$1.90+2.15%$1.90$1.7842,606 shs$64.29 million06/05/2025$1.88$1.86-1.06%$1.97$1.8423,406 shs$62.94 million06/04/2025$1.87$1.88+0.53%$1.96$1.8745,403 shs$63.61 million06/03/2025$1.75$1.87+6.86%$1.98$1.7154,528 shs$63.27 million06/02/2025$1.85$1.75-5.22%$1.86$1.6789,279 shs$59.21 million Related Companies GOSS Stock Price Chart PRME Stock Price Chart OLMA Stock Price Chart AARD Stock Price Chart SGMT Stock Price Chart RCKT Stock Price Chart LFCR Stock Price Chart AVIR Stock Price Chart IVA Stock Price Chart TKNO Stock Price Chart Receive OKYO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for OKYO Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OKYO) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredSomething very strange is happening...What a "Mar-a-Lago Accord" could mean for the U.S. dollar While protests dominate the news... hardly anyone...Stansberry Research | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OKYO Pharma Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share OKYO Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
